MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 million

- MeiraGTx enters into an Asset Purchase Agreement related to botaretigene sparoparvovec for the treatment of X-linked retinitis pigmentosa for a total of up to $415 million - MeiraGTx to receive...

Related Keywords

London ,City Of ,United Kingdom ,Jason Braco ,University College London ,Evercore Group ,Janssen Pharmaceuticals Inc ,Johnson ,Meiragtx Holdings ,Nasdaq ,Morgan Lewis Bockius ,Lifesci Communications ,Asset Purchase Agreement ,Janssen Pharmaceuticals ,Alexandria Forbes ,Morgan Lewis ,Private Securities Litigation Reform Act ,Quarterly Report ,Markets ,